BioRelix
New Haven · Founded 2005
About BioRelix
BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.
Company Facts
- Founded: 2005
- Legal name: BIORELIX, INC.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $40.7M
- Last round: Series Unknown (Apr 2012)
- Website: biorelix.com
- Phone: +1 203-785-9282
Canonical: https://fsome.com/organization/biorelix-8432806 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.